Vitor Alves Cruz

4PUBLICATIONS
49CO-AUTHORS
Major global burdens of diseaseRheumatology and arthritisInnate immunityRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 19, 2026
COVID-19 vaccine effectiveness against in-hospital mortality in immunocompromised older adults: a Brazilian hospital surveillance study, 2024.

|Mar 14, 2026
Are global definitions enough? Revisiting CDAI and SDAI remission cut-offs in Brazilian Rheumatoid Arthritis patients.

Lucas Castro Pires, Alisson Pugliesi, Cleandro Pires de Albuquerque

|Nov 22, 2025
Comparison of the immunogenicity and safety among COVID-19 vaccines ChadOx-1, CoronaVac and BNT162b2 in systemic lupus erythematosus (SLE) patients: a prospective cohort.

Priscila Dias Cardoso Ribeiro, Flavia Maria Matos Melo Campos Peixoto, Edgard Torres Dos Reis-Neto

|Aug 12, 2024
Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer.

Vitor Alves Cruz, Camila Guimarães, Jozelia Rêgo

Pageof 1

Frequent Collaborators

2 joint publications

Rodrigo Poubel Vieira de Rezende

1 joint publications

Priscila Dias Cardoso Ribeiro

1 joint publications

Edgard Torres Dos Reis-Neto

1 joint publications

Gecilmara Salviato Pileggi